Contracts › 75F40124C00094
75F40124C00094: Developing Universal Control Peptides for T-Cell Assays Supporting Immunogenicity
Awarded to Cubrc, Inc. by Food and Drug Administration (FDA).
$1.3Mobligated
$2.2Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00094 |
|---|---|
| Awardee | Cubrc, Inc. |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | H166 Quality Control- Instruments and Laboratory Equipment |
| Place of performance | NY |
| Offers received | 1 |
| Period of performance | 16 August 2024 to 30 September 2026 |
| Potential end | 30 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record